z-logo
open-access-imgOpen Access
Galnt11 regulates kidney function by glycosylating the endocytosis receptor megalin to modulate ligand binding
Author(s) -
E Tian,
Shengjun Wang,
Ping Zhang,
Ying Zhang,
May Christine V. Malicdan,
Yang Mao,
Christina Christoffersen,
Lawrence A. Tabak,
Katrine T. Schjoldager,
Kelly G. Ten Hagen
Publication year - 2019
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.1909573116
Subject(s) - endocytosis , function (biology) , microbiology and biotechnology , receptor , ligand (biochemistry) , receptor mediated endocytosis , chemistry , kidney , biology , medicine , biochemistry
Significance Chronic kidney disease (CKD) remains a major health concern worldwide, affecting ∼10% of the population. Previous genome-wide association studies have identified many genes associated with CKD, but conclusive demonstrations of their roles in kidney function remain largely unexplored. Here, we identify the mechanistic basis of one such gene by creating mice deficient forGalnt11 . We demonstrate that Galnt11 influences kidney function by site-specific modification of the endocytosis receptor megalin within the proximal tubules of the kidney. Loss ofGalnt11 results in reduced megalin-mediated ligand binding and an age-related reduction in megalin levels, resulting in low-molecular-weight proteinuria. Our results identify a factor required for proper kidney function and provide insight into its association with CKD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom